-
公开(公告)号:US20230340086A1
公开(公告)日:2023-10-26
申请号:US17596652
申请日:2019-06-19
CPC classification number: C07K16/1203 , A61K45/06 , A61P31/04 , A61K2039/55566
Abstract: Provided herein are antibodies, such as immunoglobulins Y (IgY) antibodies that inhibit beta-lactamase activity, e.g., TEM-1 beta-lactamase, as well as related compositions and methods of use thereof to treat infections by lactam-based antibiotic bacteria that produce beta-lactamase that can degrade antibiotics.